Increased Phosphaturia Accelerates The Decline in Renal Function: A Search for Mechanisms

Autor: Erena Ruiz, Juan M. Díaz-Tocados, Rosa Ortega, Alejandro Martin-Malo, Arnold J. Felsenfeld, M. Victoria Pendón-Ruiz de Mier, Escolastico Aguilera-Tejero, Pedro Aljama, M. Dolores Salmerón-Rodríguez, Mariano Rodriguez, Rafael Santamaria, Noemi Vergara, Ana I. Raya, Ana Robles, Juan R. Muñoz-Castañeda
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Male
030232 urology & nephrology
030204 cardiovascular system & hematology
medicine.disease_cause
Kidney
urologic and male genital diseases
Antioxidants
Hyperphosphatemia
0302 clinical medicine
Klotho
Hypophosphatemia
Familial

Glucuronidase
Melatonin
Aged
80 and over

Metabolic Syndrome
Multidisciplinary
Proteinuria
Overt Proteinuria
Middle Aged
female genital diseases and pregnancy complications
Medicine
Female
medicine.symptom
Excessive Phosphaturia
Hypophosphatemia
Glomerular Filtration Rate
Adult
medicine.medical_specialty
Adolescent
Science
Renal function
Article
Cell Line
Phosphates
03 medical and health sciences
Young Adult
Internal medicine
medicine
Animals
Humans
Rats
Wistar

Renal Insufficiency
Chronic

Klotho Proteins
Aged
business.industry
Klotho Expression
Kidney metabolism
medicine.disease
Rats
Rats
Zucker

Oxidative Stress
Endocrinology
HEK293 Cells
High Phosphate Concentrations
Mangiferin
business
Reactive Oxygen Species
Oxidative stress
Kidney disease
Zdroj: Scientific Reports, Vol 8, Iss 1, Pp 1-14 (2018)
Scientific Reports
ISSN: 2045-2322
Popis: In chronic kidney disease (CKD), high serum phosphate concentration is associated with cardiovascular disease and deterioration in renal function. In early CKD, the serum phosphate concentration is normal due to increased fractional excretion of phosphate. Our premise was that high phosphate intake even in patients with early CKD would result in an excessive load of phosphate causing tubular injury and accelerating renal function deterioration. In CKD 2–3 patients, we evaluated whether increased phosphaturia accelerates CKD progression. To have a uniform group of patients with early CKD, 95 patients with metabolic syndrome without overt proteinuria were followed for 2.7 ± 1.6 years. The median decline in eGFR was 0.50 ml/min/1.73 m2/year. Patients with a more rapid decrease in eGFR had greater phosphaturia. Moreover, the rate of decrease in eGFR inversely correlated with the degree of phosphaturia. Additionally, phosphaturia independently predicted renal function deterioration. In heminephrectomized rats, a high phosphate diet increased phosphaturia resulting in renal tubular damage associated with inflammation, oxidative stress and low klotho expression. Moreover, in rats with hyperphosphatemia and metabolic syndrome antioxidant treatment resulted in attenuation of renal lesions. In HEK-293 cells, high phosphate promoted oxidative stress while melatonin administration reduced ROS generation. Our findings suggest that phosphate loading in early CKD, results in renal damage and a more rapid decrease in renal function due to renal tubular injury.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje